Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Patsy Coskeran"'
Publikováno v:
Endocrine Abstracts.
Autor:
Mohamed Bakhit, Dylan Lewis, Paul Ross, Andreas Prachalias, Johnathan G.H. Hubbard, Debashis Sarker, Jennifer Clough, Simon Aylwin, Norman T Taylor, Laura May Davis, Gillian Vivian, Benjamin Whitelaw, Jackie Gilbert, David R Taylor, Lea Ghatore, Klaus-Martin Schulte, Salvador J. Diaz-Cano, Patsy Coskeran, Gabriele Galata
Publikováno v:
Endocrine Abstracts.
Introduction: Multi-modal therapy for adrenocortical carcinoma (ACC) includes surgery, therapy with the adrenolytic agent mitotane and systemic chemotherapy. Achievement of therapeutic mitotane concentrations (≥14 mg/l) has been related to improved
Publikováno v:
Autonomic Neuroscience. 89:100-109
Adult growth hormone deficient patients are known to exhibit reduced sweating and their ability to thermoregulate is diminished. Treatment of these patients with recombinant human growth hormone (r-hGH) is claimed to reverse these abnormalities. We h
Publikováno v:
Clinical Endocrinology. 51:525-529
The Gordon Holmes spinocerebellar ataxia syndrome (GHS) is associated with idiopathic hypogonadotrophic hypogonadism (IHH). There are conflicting reports in the literature as to whether the primary neuroendocrine defect is of hypothalamic GnRH secret
Autor:
John P. Miell, Teresa J. Allain, Patsy Coskeran, Simon Wessely, Jennifer Jones, Joan Butler, Anna Checkley, Jenny A. Beam
Publikováno v:
Biological Psychiatry. 41:567-573
Chronic fatigue syndrome (CFS) is characterized by severe physical and mental fatigue of central origin. Similar clinical features may occur in disorders of the hypothalamopituitary axis. The aim of the study was to determine whether patients with CF
Autor:
Simon Aylwin, Klaus-Martin Schulte, Patsy Coskeran, Norman F. Taylor, Lea Ghataore, Indira Chakraborti, Dorota Dworakowska
Publikováno v:
Endocrine Connections
Mitotane (o,p'-DDD), an oral adrenolytic agent for treatment of advanced adrenocortical carcinoma (ACC), is reported to inhibit cortisol biosynthesis in vitro and enhance production from exogenous cortisol of urinary 6β-hydroxycortisol and unidentif
Publikováno v:
Clinical Endocrinology. 33:307-316
Seven patients with large prolactin-secreting pituitary adenomas were treated for 8 weeks with once-daily doses of the new, potent, non-ergot, long-acting dopamine agonist CV205-502. In five patients previous treatment with bromocriptine had failed t
Autor:
Alan McGregor, Omar G Mustafa, Simon Aylwin, Julia Prague, Benjamin Whitelaw, Roy Sherwood, Tiana Kordbacheh, Jackie Gilbert, Dylan Lewis, Salvador J. Diaz-Cano, Patsy Coskeran
Publikováno v:
Endocrine Abstracts. :1-1
Evidence for 5-hydroxytryptamine1A receptor involvement in the control of prolactin secretion in man
Publikováno v:
Psychopharmacology. 119(3)
The effects of pindolol pretreatment (2 days) on prolactin and cortisol responses to a single dose of (+)-fenfluramine (30 mg po) were examined in nine healthy male volunteers. Pindolol pretreatment attenuated the (+)-fenfluramine-induced increase in
Autor:
Theresa Allain, Jenny Bearn, Alan McGregor, Patsy Coskeran, Neil Munro, Simon Wessely, Joan Butler
Publikováno v:
Biological psychiatry. 37(4)
Chronic fatigue syndrome (CFS) is a disorder characterized by severe physical and mental fatigue and fatiguability of central rather than peripheral origin. We hypothesized that CFS is mediated by changes in hypothalamopituitary function and so measu